(VECO) Veeco Instruments - Overview
Sector: TechnologyIndustry: Semiconductor Equipment & Materials | Exchange NASDAQ (USA) | Currency USD | Market Cap: 2.077m | Total Return 70.2% in 12m
Stock: Semiconductor Equipment, Thin Film, Deposition, Etch
Total Rating 48
Risk 78
Buy Signal 0.13
| Risk 5d forecast | |
|---|---|
| Volatility | 48.2% |
| Relative Tail Risk | -8.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.21 |
| Alpha | 41.44 |
| Character TTM | |
|---|---|
| Beta | 2.098 |
| Beta Downside | 1.584 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.20% |
| CAGR/Max DD | 0.33 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
choppy
Description: VECO Veeco Instruments March 04, 2026
Veeco Instruments Inc. (VECO) designs, manufactures, and services semiconductor and thin film processing equipment. This equipment is critical for producing electronic devices.
The companys product portfolio includes laser annealing, ion beam deposition, and chemical vapor deposition systems. These systems are utilized in the fabrication of microelectronic components such as logic chips, memory, photonics, and power electronics. The semiconductor equipment sector is characterized by high capital expenditure and rapid technological advancements.
VECO sells its products to integrated device manufacturers, foundries, outsourced semiconductor assembly and test companies, and research institutions. The company operates globally, with significant presence in Asia-Pacific, North America, and EMEA. The business model relies on both initial equipment sales and ongoing service contracts.
For more detailed financial and operational insights, further research on ValueRay is recommended.
Headlines to watch out for
- Semiconductor capital expenditure directly impacts equipment demand
- Demand for advanced packaging lithography drives revenue growth
- Geopolitical tensions affect global semiconductor supply chain
- New technology adoption in photonics and power electronics boosts sales
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 35.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.37 > 1.0 |
| NWC/Revenue: 100.4% < 20% (prev 79.78%; Δ 20.67% < -1%) |
| CFO/TA 0.05 > 3% & CFO 69.5m > Net Income 35.4m |
| Net Debt (94.4m) to EBITDA (73.6m): 1.28 < 3 |
| Current Ratio: 4.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.6m) vs 12m ago 0.16% < -2% |
| Gross Margin: 39.95% > 18% (prev 0.42%; Δ 3.95k% > 0.5%) |
| Asset Turnover: 51.55% > 50% (prev 57.31%; Δ -5.76% > 0%) |
| Interest Coverage Ratio: 5.31 > 6 (EBITDA TTM 73.6m / Interest Expense TTM 9.14m) |
Altman Z'' 1.51
| A: 0.50 (Total Current Assets 845.3m - Total Current Liabilities 178.1m) / Total Assets 1.33b |
| B: -0.32 (Retained Earnings -423.1m / Total Assets 1.33b) |
| C: 0.04 (EBIT TTM 48.5m / Avg Total Assets 1.29b) |
| D: -0.96 (Book Value of Equity -420.7m / Total Liabilities 440.3m) |
| Altman-Z'' Score: 1.51 = BB |
Beneish M -3.17
| DSRI: 0.89 (Receivables 110.7m/133.9m, Revenue 664.3m/717.3m) |
| GMI: 1.06 (GM 39.95% / 42.38%) |
| AQI: 0.95 (AQ_t 0.26 / AQ_t-1 0.28) |
| SGI: 0.93 (Revenue 664.3m / 717.3m) |
| TATA: -0.03 (NI 35.4m - CFO 69.5m) / TA 1.33b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of VECO shares?
As of March 26, 2026, the stock is trading at USD 36.96 with a total of 1,649,700 shares traded.
Over the past week, the price has changed by +19.23%, over one month by +29.87%, over three months by +26.19% and over the past year by +70.24%.
Over the past week, the price has changed by +19.23%, over one month by +29.87%, over three months by +26.19% and over the past year by +70.24%.
Is VECO a buy, sell or hold?
Veeco Instruments has received a consensus analysts rating of 4.29.
Therefore, it is recommended to buy VECO.
- StrongBuy: 4
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VECO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 33.3 | -9.8% |
| Analysts Target Price | 33.3 | -9.8% |
VECO Fundamental Data Overview March 26, 2026
P/E Trailing = 58.2881
P/E Forward = 18.2482
P/S = 3.1265
P/B = 2.0903
P/EG = 0.8072
Revenue TTM = 664.3m USD
EBIT TTM = 48.5m USD
EBITDA TTM = 73.6m USD
Long Term Debt = 226.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.06m USD (from shortTermDebt, two quarters ago)
Debt = 257.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 94.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.94b USD (2.08b + Debt 257.8m - CCE 390.2m)
Interest Coverage Ratio = 5.31 (Ebit TTM 48.5m / Interest Expense TTM 9.14m)
EV/FCF = 36.49x (Enterprise Value 1.94b / FCF TTM 53.3m)
FCF Yield = 2.74% (FCF TTM 53.3m / Enterprise Value 1.94b)
FCF Margin = 8.02% (FCF TTM 53.3m / Revenue TTM 664.3m)
Net Margin = 5.33% (Net Income TTM 35.4m / Revenue TTM 664.3m)
Gross Margin = 39.95% ((Revenue TTM 664.3m - Cost of Revenue TTM 398.9m) / Revenue TTM)
Gross Margin QoQ = 37.14% (prev 40.35%)
Tobins Q-Ratio = 1.47 (Enterprise Value 1.94b / Total Assets 1.33b)
Interest Expense / Debt = 0.84% (Interest Expense 2.18m / Debt 257.8m)
Taxrate = 10.15% (4.00m / 39.4m)
NOPAT = 43.6m (EBIT 48.5m * (1 - 10.15%))
Current Ratio = 4.75 (Total Current Assets 845.3m / Total Current Liabilities 178.1m)
Debt / Equity = 0.29 (Debt 257.8m / totalStockholderEquity, last quarter 885.5m)
Debt / EBITDA = 1.28 (Net Debt 94.4m / EBITDA 73.6m)
Debt / FCF = 1.77 (Net Debt 94.4m / FCF TTM 53.3m)
Total Stockholder Equity = 857.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.75% (Net Income 35.4m / Total Assets 1.33b)
RoE = 4.13% (Net Income TTM 35.4m / Total Stockholder Equity 857.4m)
RoCE = 4.48% (EBIT 48.5m / Capital Employed (Equity 857.4m + L.T.Debt 226.0m))
RoIC = 4.00% (NOPAT 43.6m / Invested Capital 1.09b)
WACC = 11.97% (E(2.08b)/V(2.33b) * Re(13.36%) + D(257.8m)/V(2.33b) * Rd(0.84%) * (1-Tc(0.10)))
Discount Rate = 13.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.64%
[DCF] Terminal Value 69.70% ; FCFF base≈50.3m ; Y1≈61.9m ; Y5≈105.1m
[DCF] Fair Price = 14.73 (EV 983.9m - Net Debt 94.4m = Equity 889.5m / Shares 60.4m; r=11.97% [WACC]; 5y FCF grow 24.73% → 3.0% )
EPS Correlation: -23.58 | EPS CAGR: -11.53% | SUE: -0.54 | # QB: 0
Revenue Correlation: 39.61 | Revenue CAGR: 1.44% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=+0.004 | Chg30d=-0.015 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=1.65 | Chg7d=+0.111 | Chg30d=+0.071 | Revisions Net=+3 | Growth EPS=+24.2% | Growth Revenue=+15.9%
EPS next Year (2027-12-31): EPS=2.10 | Chg7d=-0.025 | Chg30d=-0.025 | Revisions Net=+1 | Growth EPS=+26.8% | Growth Revenue=+9.5%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.6% (Discount Rate 13.4% - Earnings Yield 1.7%)
[Growth] Growth Spread = -5.1% (Analyst 6.5% - Implied 11.6%)
P/E Forward = 18.2482
P/S = 3.1265
P/B = 2.0903
P/EG = 0.8072
Revenue TTM = 664.3m USD
EBIT TTM = 48.5m USD
EBITDA TTM = 73.6m USD
Long Term Debt = 226.0m USD (from longTermDebt, last quarter)
Short Term Debt = 4.06m USD (from shortTermDebt, two quarters ago)
Debt = 257.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 94.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.94b USD (2.08b + Debt 257.8m - CCE 390.2m)
Interest Coverage Ratio = 5.31 (Ebit TTM 48.5m / Interest Expense TTM 9.14m)
EV/FCF = 36.49x (Enterprise Value 1.94b / FCF TTM 53.3m)
FCF Yield = 2.74% (FCF TTM 53.3m / Enterprise Value 1.94b)
FCF Margin = 8.02% (FCF TTM 53.3m / Revenue TTM 664.3m)
Net Margin = 5.33% (Net Income TTM 35.4m / Revenue TTM 664.3m)
Gross Margin = 39.95% ((Revenue TTM 664.3m - Cost of Revenue TTM 398.9m) / Revenue TTM)
Gross Margin QoQ = 37.14% (prev 40.35%)
Tobins Q-Ratio = 1.47 (Enterprise Value 1.94b / Total Assets 1.33b)
Interest Expense / Debt = 0.84% (Interest Expense 2.18m / Debt 257.8m)
Taxrate = 10.15% (4.00m / 39.4m)
NOPAT = 43.6m (EBIT 48.5m * (1 - 10.15%))
Current Ratio = 4.75 (Total Current Assets 845.3m / Total Current Liabilities 178.1m)
Debt / Equity = 0.29 (Debt 257.8m / totalStockholderEquity, last quarter 885.5m)
Debt / EBITDA = 1.28 (Net Debt 94.4m / EBITDA 73.6m)
Debt / FCF = 1.77 (Net Debt 94.4m / FCF TTM 53.3m)
Total Stockholder Equity = 857.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.75% (Net Income 35.4m / Total Assets 1.33b)
RoE = 4.13% (Net Income TTM 35.4m / Total Stockholder Equity 857.4m)
RoCE = 4.48% (EBIT 48.5m / Capital Employed (Equity 857.4m + L.T.Debt 226.0m))
RoIC = 4.00% (NOPAT 43.6m / Invested Capital 1.09b)
WACC = 11.97% (E(2.08b)/V(2.33b) * Re(13.36%) + D(257.8m)/V(2.33b) * Rd(0.84%) * (1-Tc(0.10)))
Discount Rate = 13.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.64%
[DCF] Terminal Value 69.70% ; FCFF base≈50.3m ; Y1≈61.9m ; Y5≈105.1m
[DCF] Fair Price = 14.73 (EV 983.9m - Net Debt 94.4m = Equity 889.5m / Shares 60.4m; r=11.97% [WACC]; 5y FCF grow 24.73% → 3.0% )
EPS Correlation: -23.58 | EPS CAGR: -11.53% | SUE: -0.54 | # QB: 0
Revenue Correlation: 39.61 | Revenue CAGR: 1.44% | SUE: 0.18 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.33 | Chg7d=+0.004 | Chg30d=-0.015 | Revisions Net=+1 | Analysts=5
EPS current Year (2026-12-31): EPS=1.65 | Chg7d=+0.111 | Chg30d=+0.071 | Revisions Net=+3 | Growth EPS=+24.2% | Growth Revenue=+15.9%
EPS next Year (2027-12-31): EPS=2.10 | Chg7d=-0.025 | Chg30d=-0.025 | Revisions Net=+1 | Growth EPS=+26.8% | Growth Revenue=+9.5%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.6% (Discount Rate 13.4% - Earnings Yield 1.7%)
[Growth] Growth Spread = -5.1% (Analyst 6.5% - Implied 11.6%)